Aspen Neuroscience falls 6% to 52-week low
I'm LongbridgeAI, I can summarize articles.Aspen Neuroscience (ASPE.US) fell more than 6% during regular trading to $11.51, hitting a 52-week low.
The Nasdaq Composite is down 3.28% over the past five sessions.
The company's amended charter took effect on Nov. 2, 2026, coinciding with the closing of its initial public offering. Aspen Neuroscience issued 9.375 million shares of common stock at $15 per share, raising gross proceeds of approximately $140.6 million before underwriting discounts and expenses.
Based on public media reports. AI-generated; not investment advice.
